Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Vollherbst, Dominik [VerfasserIn]   i
 Lücking, H. [VerfasserIn]   i
 DuPlessis, J. [VerfasserIn]   i
 Sonnberger, M. [VerfasserIn]   i
 Maurer, C. [VerfasserIn]   i
 Kocer, N. [VerfasserIn]   i
 Killer-Oberpfalzer, M. [VerfasserIn]   i
 Rautio, R. [VerfasserIn]   i
 Valvassori, L. [VerfasserIn]   i
 Berlis, A. [VerfasserIn]   i
 Gasser, S. [VerfasserIn]   i
 Gatt, S. [VerfasserIn]   i
 Dörfler, A. [VerfasserIn]   i
 Bendszus, Martin [VerfasserIn]   i
 Möhlenbruch, Markus Alfred [VerfasserIn]   i
Titel:The FRESH study
Titelzusatz:treatment of intracranial aneurysms with the new FRED X flow diverter with antithrombotic surface treatment technology - first multicenter experience in 161 patients
Verf.angabe:D.F. Vollherbst, H. Lücking, J. DuPlessis, M. Sonnberger, C. Maurer, N. Kocer, M. Killer-Oberpfalzer, R. Rautio, L. Valvassori, A. Berlis, S. Gasser, S. Gatt, A. Dörfler, M. Bendszus, and M.A. Möhlenbruch
E-Jahr:2023
Jahr:April 10, 2023
Umfang:7 S.
Fussnoten:Gesehen am 06.06.2023
Titel Quelle:Enthalten in: American journal of neuroradiology
Ort Quelle:Oak Brook, Ill. : Soc., 1980
Jahr Quelle:2023
Band/Heft Quelle:44(2023), 4 vom: Apr., Seite 474-480
ISSN Quelle:1936-959X
Abstract:BACKGROUND AND PURPOSE: Flow diverters with antithrombotic coatings are increasingly used to improve the safety of flow diverter treatments of intracranial aneurysms. This study aimed to investigate the safety and short-term efficacy of the new FRED X flow diverter. - MATERIALS AND METHODS: Medical charts and procedural and imaging data of a consecutive series of patients with intracranial aneurysms who were treated with the FRED X at 9 international neurovascular centers were retrospectively analyzed. - RESULTS: One hundred sixty-one patients (77.6% women; mean age, 55 years) with 184 aneurysms (11.2% acutely ruptured) were included in this study. Most aneurysms were located in the anterior circulation (77.0%), most frequently at the ICA (72.7%). The FRED X was successfully implanted in all procedures. Additional coiling was performed in 29.8%. In-stent balloon angioplasty was necessary in 2.5%. The rate of major adverse events was 3.1%. Thrombotic events occurred in 7 patients (4.3%) with 4 intra- and 4 postprocedural in-stent thromboses, respectively (1 patient had both peri- and postprocedural thrombosis). Of these thrombotic events, only 2 (1.2%) led to major adverse events (ischemic strokes). Postinterventional neurologic morbidity and mortality were observed in 1.9% and 1.2%, respectively. The rate of complete aneurysm occlusion after a mean follow-up of 7.0 months was 66.0%. - CONCLUSIONS: The new FRED X is a safe and feasible device for aneurysm treatment. In this retrospective multicenter study, the rate of thrombotic complications was low, and the short-term occlusion rates are satisfactory.
DOI:doi:10.3174/ajnr.A7834
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext: https://doi.org/10.3174/ajnr.A7834
 Volltext: https://www.ajnr.org/content/44/4/474
 DOI: https://doi.org/10.3174/ajnr.A7834
Datenträger:Online-Ressource
Sprache:eng
K10plus-PPN:1847476635
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/69082900   QR-Code
zum Seitenanfang